The contrasting clinical significance of POLR3G and POLR3GL gene upregulation in cancer contexts, wherein high POLR3G gene expression is associated with poor survival outcomes and high POLR3GL is not, strongly hints at important functional differences between POLR3G and POLR3GL and exposes POLR3G-driven transcription as a potential disease factor. Here, POLR3G is linked to cancer.